Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/18/2017 09/19/2017 09/20/2017 09/21/2017 09/22/2017 Date
35.55(c) 35.45(c) 35.99(c) 35.97(c) 35.96(c) Last
16 936 220 15 692 161 25 680 077 15 731 081 13 767 806 Volume
+0.54% -0.28% +1.52% -0.06% -0.03% Change
More quotes
Financials ($)
Sales 2017 52 717 M
EBIT 2017 19 912 M
Net income 2017 11 415 M
Debt 2017 23 788 M
Yield 2017 3,57%
Sales 2018 54 083 M
EBIT 2018 21 082 M
Net income 2018 12 743 M
Debt 2018 20 636 M
Yield 2018 3,75%
P/E ratio 2017 19,16
P/E ratio 2018 16,62
EV / Sales2017 4,51x
EV / Sales2018 4,34x
Capitalization 214 B
More Financials
Company
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines.It operates through the following business segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global... 
Sector
Pharmaceuticals
Calendar
10/17Presentation
More about the company
Surperformance© ratings of Pfizer
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER
09/22 PFIZER : LabCentral to Open Next-Stage Facility for Growing Life Science Compani..
09/22 PFIZER : sues J&J over Remicade contracts
09/22 PFIZER : hits a snag in bid to jump-start Sutent`s flagging kidney cancer sales
09/21 PFIZER : New Immunoglobulins Study Findings Have Been Reported by Researchers at..
09/21 TRANSGENE : First Half-Year 2017 in Line with Our Objectives: All Clinical Progr..
09/21 PFIZER : National Sickle Cell Disease Poll of African Americans Dispels Long-Hel..
09/21 PFIZER : New Global Report Finds Majority of People at High Risk of Stroke Not B..
09/21 PFIZER : Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck K..
09/21 PFIZER : National Sickle Cell Disease Poll of African Americans Dispels Long-Hel..
09/21 PFIZER : Presents Positive Pivotal Data for PF-05280014, an Investigational Bios..
More news
Sector news : Pharmaceuticals - NEC
09/22DJCorrection to Sept. 7 Harvey Rebuilding Article
09/22 Korea tensions keep European shares in check before Germany vote
09/22 Bettencourt death stirs speculation about L'Oreal ownership
09/22 China online insurer ZhongAn prices Hong Kong IPO at top end, raises $1.5 bil..
09/21DJPFIZER : Files Antitrust Lawsuit Against J&J -- WSJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on PFIZER 
PFIZER INC. - 2016
Expectation of a turn-around
BUY
PFIZER INC. - 2016
Back on a long term support level
BUY
More Strategies
Latest Tweets
09/22First Hawaiian Bank Has $203,000 Stake in Pfizer, Inc. $PFE  
09/22Pfizer, Inc. $PFE Shares Bought by Country Club Trust Company n.a.  
09/22What Do Versartis' Troubles Mean For Opko Health?
3
09/22[email protected], @VeritasGenetics, MGH Join Xconomy’s Healthcare + A.I. Conference o.. 
09/22Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Stud.. 
More tweets
Qtime:373
News from SeekingAlpha
09/22 YOUR DAILY PHARMA SCOOP : VanEck Vectors Biotech ETF, Esperion's Growth Potentia..
09/22 REDHILL BIOPHARMA : Highly De-Risked And Undervalued With A Deep Pipeline
09/22 3 THINGS IN BIOTECH YOU SHOULD LEARN : September 22, 2017
09/21 Versartis' lead candidate VRS-317 flunks late-stage study; shares poised for ..
09/21 FDA's Woodcock says clinical trials system "broken"
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 37,9 $
Spread / Average Target 5,3%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER10.81%214 146
JOHNSON & JOHNSON15.63%353 617
NOVARTIS11.88%223 850
ROCHE HOLDING LTD.6.19%221 926
MERCK AND COMPANY11.75%178 914
SANOFI9.06%126 655